One day before recreational legalization in October 2018, I’d discussed the state of the cannabis industry and what it meant for investors. At the time, I’d warned that a backward retail rollout across Canada’s provinces and other inefficiencies threatened to derail the sector before it could even get off the ground. Cannabis stocks had a brief stint as the darlings of the Canadian market, but their reputation has shifted dramatically.
A day of reckoning is on the horizon for Canada’s many cannabis companies. When legalization kicked off, experts and analysts warned that small- and medium-sized producers would experience a flurry of failures. After that, consolidation was likely. The past year and a half showed us that the largest producers are not at all immune.
Canopy Growth (TSX:WEED)(NYSE:CGC), the largest cannabis producer on the TSX, has seen its stock drop 68% year over year as of close on March 10. Aurora Cannabis (TSX:ACB)(NYSE:ACB), the second-largest cannabis stock by market cap on the TSX, has fallen 87% from the prior year. The broader market bloodbath has played a minor role in their respective retreats. Both companies are facing huge challenges in the beginning of this decade.
In the summer of 2019, Canopy Growth conceded that it would need another three to five years to turn a profit. One of the biggest hurdles for Canopy and its peers has been the slow growth of Canada’s retail footprint. In populous provinces like Ontario and Quebec, the retail footprint has expanded at a snail’s pace. This lack of availability has driven consumers back into the arms of the black market.
Canopy Growth reported net revenue of $123.8 million in the third quarter of fiscal 2020. This exceeded analyst expectations. Its adjusted EBITDA loss of $92 million was $64 million narrower than its Q2 FY 2020 results. The improvement was powered by higher sales and cost-cutting measures that lowered operating expenses.
Aurora Cannabis expected to achieve profitability in the previous fiscal year. It suffered a sharp drop when the company conceded that it would not reach this milestone. The company’s fortunes have worsened since then. Aurora lost a whopping $1.3 billion in the second quarter of fiscal 2020. Net revenue dropped 26% year over year to $56 million. Its management has been vocal about the slow pace of retail openings across Canada.
The 10 Best Stocks to Buy This MonthClick here to learn more!
Both companies have reason to be anxious about their cash situation. Canopy Growth has burned through $548 million in cash from operations in the first three quarters of FY 2020. Fortunately, the company has made progress with its cost cutting, even if it still has a long way to go. Canopy Growth got a huge cash boost from its Constellation Brands partnership, and now it needs to slash cash burn to survive and reach profitability.
The situation has been more dire at Aurora Cannabis. As it stands today, Aurora has less than one year of cash runway. Investors have been hoping for that elusive partnership and injection of cash, but such a deal appears remote, as larger investors have soured on the sector. In early February, Aurora was one of the worst-positioned Canadian producers with 2.3 months of liquidity.
These are risky assets right now, but I prefer Canopy Growth with its preferable cash position in early March. Aurora still has high growth potential, but it is in a fight for survival right now, and there are no guarantees in this disappointing sector.
Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you.
Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.